Effect of Exercise Therapy on Non-Obese Women with Polycystic Ovary Syndrome: A Protocol for a Randomized Controlled Trial
Abstract
Background: Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting up to 13% of women of reproductive age, with associated reproductive, metabolic, and psychological complications. While lifestyle interventions, particularly exercise therapy, are crucial in managing PCOS in obese individuals, their impact on nonobese patients remains inadequately explored. This study aims to assess the effects of exercise therapy on menstrual regularity, hormonal profiles, and metabolic parameters in nonobese women with PCOS. Methods: This protocol outlines a single-blind, randomized controlled trial (RCT). Forty-eight nonobese women with PCOS (body mass index ≤25) meeting the inclusion criteria were enrolled and randomized into three groups: aerobic exercise with usual care (US), resistance exercise with UC, and UC alone. The interventions spanned 12 weeks, with assessments at baseline, 4, 8, and 12 weeks. Primary outcomes include menstrual regularity and anthropometric indices, while secondary outcomes encompass hormonal levels, insulin resistance, and ovarian morphology. Data analysis was performed using SPSS version 27.0, with statistical significance set at p .
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.